---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-014353"
form_type: "8-K"
ticker: "IVF"
cik: "0001417926"
company_name: "INVO Fertility, Inc."
filed_at: "2024-04-11T23:59:59+00:00"
generated_at: "2026-06-03T23:59:03.395771+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# INVO Bioscience raises $250K via convertible note and warrants; 12% interest, 1-yr maturity

## Summary
- Issued $275,000 convertible note to FirstFire Global Opportunities Fund for $250,000 purchase price after fees.
- Note convertible at $1.00/share, 12% interest, 12-month maturity; prepayable at 110%.
- Warrants: 229,167 shares at $1.20 (immediate, 5-yr); 500,000 shares at $0.01 (on default).
- Also issued 50,000 commitment shares; proceeds for working capital and general corporate purposes.
- Stockholder approval needed within 9 months if issuances exceed 19.99% of outstanding (523,344 shares).

## SEC filing metadata
- accession: 0001493152-24-014353
- form_type: 8-K
- ticker: IVF
- cik: 0001417926
- company_name: INVO Fertility, Inc.
- filed_at: 2024-04-11T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 2.03, 3.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417926/000149315224014353/0001493152-24-014353-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417926/000149315224014353/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-014353
- JSON: https://secwatch.observer/filing/0001493152-24-014353.json
- Plain text: https://secwatch.observer/filing/0001493152-24-014353.txt

## Key facts
- Debt Financings
  INVO Fertility, Inc. incurred convertible notes of $275,000.00 with FirstFire Global Opportunities Fund, LLC at twelve percent (12%) per annum maturing twelve (12) months from the issue date.
  - Instrument: convertible notes
  - Principal: $275,000.00
  - Counterparty: FirstFire Global Opportunities Fund, LLC
  - Rate: twelve percent (12%) per annum
  - Maturity: twelve (12) months from the issue date
  - Event: incurrence
  source text: On April 5, 2024, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into a purchase agreement (the “ Purchase Agreement ”) with FirstFire Global Opportunities Fund, LLC (the “ Buyer ”), pursuant to which the Buyer agreed to purchase, and the Company agreed to issue and sell, (i) a promissory note with an aggregate principal amount of $275,000.00, which is convertible into shares of the Company’s common stock
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224014353/0001493152-24-014353-index.htm
- Material Agreements
  INVO Fertility, Inc. entered into Purchase Agreement with FirstFire Global Opportunities Fund, LLC valued at $275,000 (effective 2024-04-05).
  - Action: entry
  - Agreement: equity purchase
  - Counterparty: FirstFire Global Opportunities Fund, LLC
  - Value: $275,000
  - Effective: 2024-04-05
  source text: On April 5, 2024, INVO Bioscience, Inc., a Nevada corporation (the “ Company ”) entered into a purchase agreement (the “ Purchase Agreement ”) with FirstFire Global Opportunities Fund, LLC (the “ Buyer ”), pursuant to which the Buyer agreed to purchase, and the Company agreed to issue and sell, (i) a promissory note with an aggregate principal amount of $275,000.00
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417926/000149315224014353/0001493152-24-014353-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.